Epidemiology of bone cancer in Saudi Arabia: a nationwide population-based study (2004–2020) - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

National Epidemiological Analysis of Bone Cancer in Saudi Arabia: A Population-Based Study from 2004 to 2020

  • By

  • Ibrahim G. Alghamdi

  • Hasan A Alaidarous

  • Murad I Alghamdi

  • Khalid A Alghamdi

  • Musharraf A Alghamdi

  • Mazen S Alghamdi

  • Anas A Alzahrani

  • Tariq A Alghamdi

  • Osama M Alomari

  • Khalid S Alghamdi

  • Mohammed M Alzahrani

  • Ragad A Alzahrani

  • Hazim H Alsadi

  • June 26, 2026

Share

  • 1

    A total of 2,275 primary bone cancer cases were recorded in Saudi Arabia from 2004 to 2020, with a male predominance of 57.9%.

  • 2

    Bone cancer accounted for approximately 2.0% of all cancers in males and 0.9% in females during the study period.

  • 3

    The mean age-standardized incidence rates were higher in males (≈1.0 per 100,000) compared to females (≈0.7 per 100,000).

  • 4

    The age-specific incidence showed a peak in adolescents, particularly in the 15–19-year age group, followed by the 10–14-year group.

  • 5

    Regional variations in age-standardized incidence rates were noted, with higher rates in Al-Jouf and Najran and lower rates in Jazan.

Original Source(s)

Epidemiology of bone cancer in Saudi Arabia: a nationwide population-based study (2004–2020)

  • by Ibrahim G. Alghamdi, Hasan A Alaidarous, Murad I Alghamdi, Khalid A Alghamdi, Musharraf A Alghamdi, Mazen S Alghamdi, Anas A Alzahrani, Tariq A Alghamdi, Osama M Alomari, Khalid S Alghamdi, Mohammed M Alzahrani, Ragad A Alzahrani, Hazim H Alsadi

  • June 26, 2026

Related Content

Venetoclax plus azacitidine in higher-risk myelodysplastic syndromes: a treatment-purpose framework for interpreting response depth

Sertoli cell tumor in familial adenomatous polyposis: a case report

Commentary: Impact of HPV vaccine on CIN2+ recurrence after conization: a systematic review and meta-analysis of vaccination timing, valency and surgical margins